Cocrystal Pharma Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Cocrystal Pharma Inc.

Cocrystal Pharma Inc. | Cash Flow

No data

About Cocrystal Pharma

View Profile

Address	19805 North Creek Parkway Bothell Washington 98011 United States
Employees	-
Website	http://www.cocrystalpharma.com
Updated	07/08/2019
Cocrystal Pharma, Inc. is a clinical stage biotechnology company, which engages in discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of Hepatitis C. Phase 1b studies in Hepatitis C infected patients showed the largest reduction in viral load of any non-neoside inhibitor tested to date.